Format

Send to

Choose Destination
Sci Rep. 2019 Mar 15;9(1):4960. doi: 10.1038/s41598-018-37926-4.

Author Correction: Laquinimod treatment in the R6/2 mouse model.

Author information

1
Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany. gisa.ellrichmann@rub.de.
2
Center of Clinical Research, Ruhr-University Bochum, Bochum, Germany.
3
Galmed Pharmaceuticals, Tel Aviv, Israel.
4
Teva Pharmaceutical Industries Ltd, Tiqva, Israel.
5
Department of Molecular Cell Biology, Institute of Biochemistry and Pathobiochemistry, Ruhr-University Bochum, Bochum, Germany.
6
Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.

Abstract

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center